DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $35.4 million in its first quarter.
The Durham, North Carolina-based company said it had a loss of 17 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The drugmaker posted revenue of $92.8 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $85.6 million.
The company’s shares closed at $4.45. A year ago, they were trading at $8.47.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
